ZXDA
geneOn this page
Also known as ZNF896
Summary
ZXDA (zinc finger X-linked duplicated A, HGNC:13198) is a protein-coding gene on chromosome Xp11.21, encoding Zinc finger X-linked protein ZXDA (P98168). Cooperates with CIITA to promote transcription of MHC class I and MHC class II genes.
This gene encodes one of two duplicated zinc finger genes on chromosome Xp11. This gene is the telomeric copy; GeneID 158586 ZXDB is the more centromeric copy. The two genes have 98% nucleotide sequence similarity, and the predicted proteins contain 10 tandem zinc finger motifs.
Source: NCBI Gene 7789 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 82 total
- MANE Select transcript:
NM_007156
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13198 |
| Approved symbol | ZXDA |
| Name | zinc finger X-linked duplicated A |
| Location | Xp11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF896 |
| Ensembl gene | ENSG00000198205 |
| Ensembl biotype | protein_coding |
| OMIM | 300235 |
| Entrez | 7789 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000358697
RefSeq mRNA: 1 — MANE Select: NM_007156
NM_007156
CCDS: CCDS14376
Canonical transcript exons
ENST00000358697 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001414587 | 57905430 | 57910458 |
Expression profiles
Bgee: expression breadth ubiquitous, 208 present calls, max score 85.15.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5574 / max 24.9916, expressed in 84 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199434 | 0.3904 | 74 |
| 199432 | 0.1045 | 61 |
| 199433 | 0.0625 | 45 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 85.15 | gold quality |
| buccal mucosa cell | CL:0002336 | 84.19 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.76 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.56 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 74.82 | gold quality |
| cortical plate | UBERON:0005343 | 74.27 | gold quality |
| tendon | UBERON:0000043 | 73.10 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.80 | gold quality |
| ventricular zone | UBERON:0003053 | 72.28 | gold quality |
| tibia | UBERON:0000979 | 72.09 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 71.27 | silver quality |
| islet of Langerhans | UBERON:0000006 | 71.15 | gold quality |
| medial globus pallidus | UBERON:0002477 | 71.08 | silver quality |
| stromal cell of endometrium | CL:0002255 | 71.05 | gold quality |
| parietal pleura | UBERON:0002400 | 71.01 | gold quality |
| cauda epididymis | UBERON:0004360 | 70.21 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.03 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 69.79 | silver quality |
| pleura | UBERON:0000977 | 69.74 | gold quality |
| caput epididymis | UBERON:0004358 | 69.13 | gold quality |
| corpus epididymis | UBERON:0004359 | 69.12 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.65 | gold quality |
| visceral pleura | UBERON:0002401 | 68.60 | gold quality |
| biceps brachii | UBERON:0001507 | 68.47 | silver quality |
| deltoid | UBERON:0001476 | 68.46 | silver quality |
| skin of hip | UBERON:0001554 | 68.10 | gold quality |
| muscle of leg | UBERON:0001383 | 67.71 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 67.20 | gold quality |
| globus pallidus | UBERON:0001875 | 66.89 | silver quality |
| muscle organ | UBERON:0001630 | 66.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.58 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
3 targets.
| Target | Regulation |
|---|---|
| CD74 | |
| CDKN2A | |
| HLA-E |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2596.1 | ZXDA | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
miRNA regulators (miRDB)
126 targeting ZXDA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
Literature-anchored findings (GeneRIF, showing 2)
- ZXDA and ZXDC form an important regulatory complex for MHC II gene transcription. (PMID:17493635)
- Role of ZXD proteins in regulating MHC II transcription. (PMID:19777325)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-156n14.3 | ENSDARG00000052351 |
| danio_rerio | zic6 | ENSDARG00000071496 |
| drosophila_melanogaster | opa | FBGN0003002 |
| drosophila_melanogaster | ci | FBGN0004859 |
| drosophila_melanogaster | lmd | FBGN0039039 |
| caenorhabditis_elegans | WBGENE00004335 | |
| caenorhabditis_elegans | WBGENE00006604 | |
| caenorhabditis_elegans | WBGENE00010936 |
Paralogs (14): ZIC2 (ENSG00000043355), ZXDC (ENSG00000070476), GLI2 (ENSG00000074047), GLI3 (ENSG00000106571), GLIS3 (ENSG00000107249), GLI1 (ENSG00000111087), GLIS2 (ENSG00000126603), AEBP2 (ENSG00000139154), ZIC5 (ENSG00000139800), ZIC1 (ENSG00000152977), ZIC3 (ENSG00000156925), GLIS1 (ENSG00000174332), ZIC4 (ENSG00000174963), ZXDB (ENSG00000198455)
Protein
Protein identifiers
Zinc finger X-linked protein ZXDA — P98168 (reviewed: P98168)
All UniProt accessions (1): P98168
UniProt curated annotations — full annotation on UniProt →
Function. Cooperates with CIITA to promote transcription of MHC class I and MHC class II genes.
Subunit / interactions. Self-associates. Interacts with ZXDC and CIITA.
Subcellular location. Nucleus.
Tissue specificity. May be expressed in brain, heart, kidney, liver, lung, muscle and placenta.
Similarity. Belongs to the ZXD family.
RefSeq proteins (1): NP_009087* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051061 |
Pfam: PF00096, PF13912
UniProt features (17 total): zinc finger region 10, region of interest 3, sequence variant 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P98168-F1 | 55.14 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 57 (showing top):
CTGAGCC_MIR24, GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING, HAMAI_APOPTOSIS_VIA_TRAIL_UP, GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY, chrXp11, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR8485, MIR651_3P, MIR5696, MIR340_5P, MIR30B_5P_MIR30C_5P, MIR30D_5P, MIR30E_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of DNA-templated transcription (GO:0045893)
GO Molecular Function (6): transcription coregulator activity (GO:0003712), transcription coactivator activity (GO:0003713), zinc ion binding (GO:0008270), C2H2 zinc finger domain binding (GO:0070742), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| transcription regulator activity | 1 |
| transcription coregulator activity | 1 |
| positive regulation of DNA-templated transcription | 1 |
| transition metal ion binding | 1 |
| protein domain specific binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
516 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZXDA | ZXDC | Q2QGD7 | 799 |
| ZXDA | DPY19L3 | Q6ZPD9 | 376 |
| ZXDA | MANEAL | Q5VSG8 | 362 |
| ZXDA | ACVR1C | Q8NER5 | 349 |
| ZXDA | PRPSAP1 | Q14558 | 349 |
| ZXDA | RTL9 | Q8NET4 | 348 |
| ZXDA | PPP1R3G | B7ZBB8 | 336 |
| ZXDA | OCRL | Q01968 | 332 |
| ZXDA | TCF15 | Q12870 | 328 |
| ZXDA | PLEKHH2 | Q8IVE3 | 323 |
| ZXDA | NALF2 | O75949 | 321 |
| ZXDA | NLRP13 | Q86W25 | 317 |
| ZXDA | ZC3H8 | Q8N5P1 | 315 |
| ZXDA | MARCHF10 | Q8NA82 | 315 |
| ZXDA | CHST10 | O43529 | 307 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZXDC | CIITA | psi-mi:“MI:0914”(association) | 0.670 |
| ZXDA | ZXDC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZXDA | CIITA | psi-mi:“MI:0915”(physical association) | 0.480 |
| CIITA | ZXDA | psi-mi:“MI:0915”(physical association) | 0.480 |
| ZXDA | CIITA | psi-mi:“MI:0914”(association) | 0.480 |
| ZXDA | ZXDA | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (19): ZXDA (Affinity Capture-RNA), ZXDA (Affinity Capture-MS), FBXO38 (Affinity Capture-Western), CUL1 (Affinity Capture-Western), SKP1 (Affinity Capture-Western), CSNK2A1 (Affinity Capture-MS), CSNK2A2 (Affinity Capture-MS), FBXO38 (Affinity Capture-MS), CENPB (Affinity Capture-MS), PPP6C (Affinity Capture-MS), PPP2R2A (Affinity Capture-MS), RBX1 (Affinity Capture-MS), SUGT1 (Affinity Capture-MS), CUL1 (Affinity Capture-MS), SKP1 (Affinity Capture-MS)
ESM2 similar proteins: A0JNJ4, A2APT9, A6NEL2, A6NP61, B1ASB6, B1WBS3, B2RXF5, F6WEQ6, O15015, O43918, O88282, O88286, O95785, P98168, P98169, Q2M3G4, Q2MHN3, Q2QGD7, Q3U1J1, Q3U381, Q497V6, Q5SW24, Q5SXM2, Q6YND2, Q6ZMQ8, Q6ZMY3, Q7TN08, Q7TSX9, Q80SU3, Q80YE4, Q811H0, Q8BG26, Q8BZW2, Q8C8V1, Q8IX07, Q8IY92, Q8N143, Q8N1G0, Q8NC74, Q8TBE0
Diamond homologs: A2CE44, P98168, P98169, Q2QGD7, Q8C8V1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
82 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
5 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:57910300:TGGGG:T | donor_gain | 0.4200 |
| X:57910102:G:T | donor_gain | 0.3100 |
| X:57910132:C:T | donor_gain | 0.3000 |
| X:57910133:C:T | donor_gain | 0.2400 |
| X:57910137:G:T | donor_gain | 0.2400 |
AlphaMissense
5233 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:57908858:G:C | F521L | 1.000 |
| X:57908858:G:T | F521L | 1.000 |
| X:57908859:A:G | F521S | 1.000 |
| X:57908860:A:G | F521L | 1.000 |
| X:57908891:G:C | F510L | 1.000 |
| X:57908891:G:T | F510L | 1.000 |
| X:57908893:A:G | F510L | 1.000 |
| X:57908921:G:C | H500Q | 1.000 |
| X:57908921:G:T | H500Q | 1.000 |
| X:57908923:G:C | H500D | 1.000 |
| X:57908931:A:G | L497P | 1.000 |
| X:57908943:C:A | R493M | 1.000 |
| X:57908948:G:C | F491L | 1.000 |
| X:57908948:G:T | F491L | 1.000 |
| X:57908949:A:G | F491S | 1.000 |
| X:57908950:A:G | F491L | 1.000 |
| X:57908977:A:G | C482R | 1.000 |
| X:57909011:G:C | H470Q | 1.000 |
| X:57909011:G:T | H470Q | 1.000 |
| X:57909013:G:C | H470D | 1.000 |
| X:57909013:G:T | H470N | 1.000 |
| X:57909015:C:A | R469M | 1.000 |
| X:57909021:A:G | L467P | 1.000 |
| X:57909032:G:C | S463R | 1.000 |
| X:57909032:G:T | S463R | 1.000 |
| X:57909034:T:G | S463R | 1.000 |
| X:57909038:G:C | F461L | 1.000 |
| X:57909038:G:T | F461L | 1.000 |
| X:57909039:A:G | F461S | 1.000 |
| X:57909040:A:G | F461L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000033789 (X:57907602 A>T), RS1000187148 (X:57906608 C>T), RS1003409086 (X:57907424 T>C), RS1003582238 (X:57906064 G>A), RS1004485075 (X:57910449 C>T), RS1004854589 (X:57905300 C>T), RS1005227330 (X:57908467 C>A,T), RS1005242750 (X:57911771 TTTCTTTC>T), RS1005526373 (X:57905666 T>C), RS1005896195 (X:57912129 T>C), RS1009258590 (X:57907700 G>A), RS1010072115 (X:57906126 G>A), RS1010338422 (X:57906729 A>G), RS1010453779 (X:57906699 T>A,G), RS1010619098 (X:57907324 T>C)
Disease associations
OMIM: gene MIM:300235 | disease phenotypes: MIM:617667
GenCC curated gene-disease
Mondo (1): Fraser syndrome 3 (MONDO:0054739)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002040_3 | Blood trace element (Zn levels) | 1.000000e-12 |
| GCST003983_8 | Male-pattern baldness | 6.000000e-20 |
| GCST006661_307 | Male-pattern baldness | 1.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 2 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| 2-methyl-4-isothiazolin-3-one | decreases expression | 1 |
| hydroxyhydroquinone | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Cadmium | increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Urethane | affects expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alopecia, androgenetic alopecia, Fraser syndrome 3